~~<i id='73593C9D38'><strike id='73593C9D38'><tt id='73593C9D38'><pre id='73593C9D38'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：fashion 2025-09-03 18:41:11 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： FDA gives detailed accounting of AI

focus

hotspot

focus

hotspot

Wikipedia

MollyFerguson/STATIttookAnavexLifeSciencessevenmonthstofinallyacknowledgethefailureofalate-stageclin

WSS

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Ahead of JPM, here's who's profiting most in health care

HHS leader on health, climate change and biopharma emissions

Lawmakers consider Medicare pay reforms for doctors

Burning questions for the 2024 JPM Healthcare Conference

STAT Summit: Biotech founders on deal

hotspot

explore

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Morgan Health, with ambitious aims, wants you to know it’s still here

Apple is now the first public company to be valued at $3 trillion

Burning questions for the 2024 JPM Healthcare Conference

Psychedelics group wrestles with new pharma identity

Why health workers in Gaza are injured or die at high rates

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Researchers explore possible ties between long Covid, menopause

DIEP, the 'gold standard' of breast reconstruction, is under threat

Will Ozempic

hotspot

Researchers explore possible ties between long Covid, menopause

Feng Zhang CRISPR delivery startup lays off quarter of staff

GSK Flovent asthma inhalers replaced by authorized generics

GSK Flovent asthma inhalers replaced by authorized generics

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

White House finalizes ITC's import ban of latest Apple Watches

focus

hotspot

hotspot

Wikipedia